Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Westlake Chemical Partners (WLKP) Gains from Investment Securities (2017 - 2025)

Historic Gains from Investment Securities for Westlake Chemical Partners (WLKP) over the last 11 years, with Q3 2025 value amounting to -$59000.0.

  • Westlake Chemical Partners' Gains from Investment Securities fell 20000.0% to -$59000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $76000.0, marking a year-over-year increase of 26888.89%. This contributed to the annual value of $182000.0 for FY2024, which is 57407.41% up from last year.
  • As of Q3 2025, Westlake Chemical Partners' Gains from Investment Securities stood at -$59000.0, which was down 20000.0% from $104000.0 recorded in Q2 2025.
  • In the past 5 years, Westlake Chemical Partners' Gains from Investment Securities registered a high of $4.0 million during Q4 2022, and its lowest value of -$2.4 million during Q2 2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was -$59000.0 (2023), whereas its average is $1947.4.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 55138.34% in 2021, then tumbled by 86310.68% in 2022.
  • Quarter analysis of 5 years shows Westlake Chemical Partners' Gains from Investment Securities stood at $1.1 million in 2021, then skyrocketed by 254.12% to $4.0 million in 2022, then plummeted by 101.46% to -$59000.0 in 2023, then surged by 384.75% to $168000.0 in 2024, then crashed by 135.12% to -$59000.0 in 2025.
  • Its Gains from Investment Securities stands at -$59000.0 for Q3 2025, versus $104000.0 for Q2 2025 and -$137000.0 for Q1 2025.